Lanthanum Carbonate Tablet, Chewable
Product Images NDC 69097-935

10 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lanthanum Carbonate (NDC 69097-935). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lanthanum-01. (Lanthanum 01)

Lanthanum-01. (Lanthanum 01)
A line graph depicting the difference in phosphorus reduction (mg/dL) versus placebo by dose of lanthanum carbonate (225 mg, 675 mg, 1350 mg, 2250 mg). The graph shows a trend of increasing phosphorus reduction with higher doses of lanthanum carbonate, with error bars indicating variability at each dose level.*
FDA Label Image

Lanthanum-02.jpg (Lanthanum 02)

Lanthanum-02.jpg (Lanthanum 02)
This packaging label is for Lanthanum Carbonate chewable tablets, 500 mg strength, marketed by Cipla USA Inc. The label states that each package contains 2 bottles with 45 chewable tablets each. It includes instructions for patients to not swallow tablets whole and to chew or crush completely before swallowing. The label also provides manufacturer and storage information, along with a barcode and Rx only designation.*
FDA Label Image

Lanthanum-03.jpg (Lanthanum 03)

Lanthanum-03.jpg (Lanthanum 03)
Lanthanum Carbonate 750 mg chewable tablets packaging label from Cipla USA Inc. The carton is labeled for a 6-bottle supply, each bottle containing 15 chewable tablets. The label includes directions to not swallow tablets whole but to chew or crush completely before swallowing, with or immediately after meals. It lists the labeler and manufacturer addresses and states each package is designed as one month's therapy.*
FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Package)

Principal Display Panel (1000 mg Tablet Bottle Package)
The packaging label for Lanthanum Carbonate chewable tablets 1000 mg by Cipla USA Inc. The carton contains 9 bottles, each with 10 chewable tablets. The label includes directions to not swallow tablets whole and to chew or crush completely before swallowing. It also provides patient and pharmacist instructions and manufacturing details.*
FDA Label Image

500mg. (500mg)

500mg. (500mg)
Label for Lanthanum Carbonate chewable tablets, 500 mg strength, supplied by Cipla USA Inc. The label includes dosage form as chewable tablets, package count of 45 tablets, with directions to chew or crush tablets before swallowing. It also lists the active ingredient amount per tablet and manufacturer information for Genvion Corporation and Cipla USA Inc.*
FDA Label Image

750mg Label. (750mg Label)

750mg Label. (750mg Label)
Label for Lanthanum Carbonate chewable tablets, 750 mg strength. The label states the tablets should be chewed or crushed before swallowing and taken with or immediately after meals. It includes storage instructions at 20° to 25°C and lists inactive ingredients. Manufactured by Genvion Corporation and labeled for Cipla USA Inc. The package contains 15 tablets.*
FDA Label Image

1000mg. (1000mg)

1000mg. (1000mg)
Label for Lanthanum Carbonate chewable tablets, 1000 mg strength, oral dosage form. The label specifies the active ingredient as 1000 mg of lanthanum as lanthanum carbonate anhydrous per tablet. It includes administration instructions to chew or crush tablets before swallowing and to take with or immediately after meals. The product contains 10 tablets per package and is labeled for prescription use only. Manufacturer information lists Genvion Corporation and Cipla USA Inc. as the labeler.*
FDA Label Image

500mg Carton. (500mg Carton)

500mg Carton. (500mg Carton)
Lanthanum Carbonate chewable tablets 500 mg carton label by Cipla USA Inc. The label states the product is for oral use with chewable tablets. The carton contains 2 bottles with 45 chewable tablets each. Warnings include not swallowing whole tablets, instructions for pharmacists, and patient information contacts. The NDC number 69097-934-98 is shown along with storage and handling details.*
FDA Label Image

750mg Carton. (750mg Carton)

750mg Carton. (750mg Carton)
Lanthanum carbonate 750 mg chewable tablets packaging label for oral use by Cipla USA Inc. The label indicates a prescription drug in a package containing 6 bottles with a total of 15 chewable tablets each. It includes directions to chew or crush tablets completely before swallowing and a patient medication guide note. The label lists active and inactive ingredients and manufacturer information for Gensys Corporation and Cipla USA.*
FDA Label Image

1000mg Carton. (1000mg Carton)

1000mg Carton. (1000mg Carton)
Carton label for Lanthanum Carbonate chewable tablets, 1000 mg strength, produced by Cipla USA Inc. The label indicates the packaging contains 9 chewable tablets per bottle and specifies oral use. It includes directions to avoid swallowing tablets whole and a note that the package is a one-month supply. The NDC is 69897-936-06.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.